International Journal of Radiation Oncology * Biology * Physics
Volume 69, Issue 4 , Pages 1205-1208, 15 November 2007

Postoperative High-Dose-Rate Brachytherapy in the Prevention of Keloids

  • Ronald E. Veen, M.D., Ph.D.

      Affiliations

    • Corresponding Author InformationReprint requests to: Ronald E. Veen, M.D., Ph.D., University Medical Center, Department of Radiation Oncology, Q 00.118, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. Tel: (+31) 30-250-8800; Fax: (+31) 30-258-1226
  • ,
  • Henk B. Kal, Ph.D.

Department of Radiotherapy, University Medical Center, Utrecht, The Netherlands

Received 28 September 2006; received in revised form 26 March 2007; accepted 21 April 2007.

Background

The aim of this study is to show the efficiency of keloidectomy and postoperative interstitial high-dose-rate (HDR) brachytherapy in the prevention of keloids.

Methods and Materials

Between 1998 and 2004, 35 patients with 54 keloids were treated postoperatively with HDR brachytherapy. The first HDR dose was applied within 6 hours after surgery, and two additional HDR doses were administered on the next day with a six-hour interval. The majority of patients received 6 Gy as the first dose postsurgery and two fractions of 4 Gy (38 keloids) on the next day. Seven keloids were treated postoperatively with three fractions of 6 Gy. The biologically effective dose (BED), derived from the linear quadratic concept, was applied to calculate the BED for the various radiation regimens. The keloid recurrence rates at specific BED values were compared with those derived for other fractionation schemes in the literature.

Results

Four recurrences/nonsatisfactory results out of nine treated keloids were observed after treatments with 1 × 4 Gy + 2 × 3 Gy. Only one recurrence out of 38 was found after 1 × 6 Gy + 2 × 4 Gy and none after 3 × 6 Gy. Better cosmetic results were found at the higher-dose schemes.

Conclusion

The results of this study prove the effectiveness of HDR brachytherapy after keloidectomy provided that the total HDR dose is sufficient. Currently our scheme is 3 × 6 Gy.

High-dose-rate brachytherapy, Keloids, Postoperative radiotherapy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflict of interest: none.

PII: S0360-3016(07)00756-0

doi:10.1016/j.ijrobp.2007.04.032

International Journal of Radiation Oncology * Biology * Physics
Volume 69, Issue 4 , Pages 1205-1208, 15 November 2007